• Focus: diverse range of clinical areas, particularly associated with inflammatory and degenerative diseases
  • Main scientific fields: inflammatory bowel disease, rheumatic diseases, inflammatory skin diseases, neurological inflammatory diseases, critical care, biomarkers, medicine, drugs and drugs development, medical microbiology, ageing, dementia and neuronal degeneration
  • Relevance: a bidirectional flow between bench and patient , turning fundamental research an essential support to patient care


Fernando Magro

MD. PhD.

Coordinator: Fernando Magro graduated in Medicine. He holds a Doctorate from the Faculty of Medicine of the University of Porto (FMUP). Currently, he is a Guest Associate Professor at FMUP, a Consultant in Gastroenterology at the University Hospital Center of São João (Porto), founder and member of the Study Group on Inflammatory Bowel Disease (GEDII), a member of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD), a member of the governing board of the European Crohn and Colitis Organization (ECCO), an ECCO educational officer and an Associate Editor of the United European Gastroenterology Journal (UEG). His main research interests are gastrointestinal diseases, inflammatory bowel disease management, treatment and prognosis, and clinical pharmacology (h-index: 48).

Acácio Rodrigues graduated in Medicine from the Faculty of Medicine of the University of Porto. He holds a Doctorate in the same field and is a specialist in Anaesthesia and Intensive Care with a subspecialty in Emergency Medicine.
He coordinates the MicroMed – Medical Microbiology research group of CINTESIS. He is an Associate Professor with Aggregation at FMUP and the Head of the Laboratory of Microbiology. Moreover, he works as a Medical Doctor at the University Hospital Centre of São João. His main research areas are Microbiology, Infectious Diseases, Mycology, Dermatology, Pharmacology, and Pharmacy. His team is testing a new strategy for disinfecting hospital surfaces to reduce the risk of infections, especially by pathogenic microorganisms resistant to drugs. He also participates in projects funded by the RESEARCH 4 COVID-19 initiative, aiming to implement innovative solutions to the pandemic caused by the new coronavirus (SARS-CoV-2).

Jorge Polónia

MD. PhD.

Jorge Polónia is Head of the PhamaHTA group at CINTESIS. He is also the Coordinator of the Pharmacovigilance Unit of Porto, a Consultant of Medicine and Hypertension at the Pedro Hispano Hospital, an Associate Professor of the Faculty of Medicine of University of Porto (FMUP), a Guest Full Professor at the University of Aveiro, and a Member of the Council of the European Society of Hypertension. He earned his graduate degree and doctorate from FMUP, specialising in Pharmacology and Clinical and Internal Medicine. His CV includes more than a hundred scientific articles published in international journals, several of them have won important awards. In the last decade, this researcher has developed his pioneering study on hypertension and salt consumption in Portugal (PHYSA study), his main research area. Through his work, Jorge Polónia aims to identify the modifiable factors that determine the excess mortality from stroke in Portugal, thus contributing to health promotion solutions.

Roberto Roncon de Albuquerque is an Intensive Care Specialist. He coordinates the Extracorporeal Membrane Oxygenation (ECMO) Reference Center of the University Hospital Center of São João. He is also a researcher at UNIC and a Guest Assistant Professor at the Faculty of Medicine of the University of Porto (FMUP). He earned his Doctorate in Medicine from FMUP with the work “Modulation of Innate Immunity by Nutritional Status: Implications for Cardiac and Renal Pathophysiology.” Roncon de Albuquerque has authored more than 50 articles published in international scientific journals and has won about 40 awards for his work in cardiovascular diseases, ECMO, and intensive care medicine. His work in the field of ECMO and Intensive Care within one of the largest Portuguese hospitals has turned out to be of the utmost importance in the current context of the Covid-19 pandemic, making him a leading figure in the national health landscape.